Targeting cytokine and chemokine signaling pathways for cancer therapy

M Yi, T Li, M Niu, H Zhang, Y Wu, K Wu… - Signal transduction and …, 2024 - nature.com
Cytokines are critical in regulating immune responses and cellular behavior, playing dual
roles in both normal physiology and the pathology of diseases such as cancer. These …

Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives

X Shi, X Wang, W Yao, D Shi, X Shao, Z Lu… - Signal transduction and …, 2024 - nature.com
Metastasis remains a pivotal characteristic of cancer and is the primary contributor to cancer-
associated mortality. Despite its significance, the mechanisms governing metastasis are not …

Current and future immunotherapeutic approaches in pancreatic cancer treatment

P Farhangnia, H Khorramdelazad, H Nickho… - Journal of Hematology & …, 2024 - Springer
Pancreatic cancer is a major cause of cancer-related death, but despondently, the outlook
and prognosis for this resistant type of tumor have remained grim for a long time. Currently, it …

IL-2-driven CD8+ T cell phenotypes: implications for immunotherapy

V Niederlova, O Tsyklauri, M Kovar, O Stepanek - Trends in immunology, 2023 - cell.com
The therapeutic potential of interleukin (IL)-2 in cancer treatment has been known for
decades, yet its widespread adoption in clinical practice remains limited. Recently, chimeric …

Multi-stage mechanisms of tumor metastasis and therapeutic strategies

Z Liu, J Chen, Y Ren, S Liu, Y Ba, A Zuo… - … and Targeted Therapy, 2024 - nature.com
The cascade of metastasis in tumor cells, exhibiting organ-specific tendencies, may occur at
numerous phases of the disease and progress under intense evolutionary pressures. Organ …

Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8+ T cell effector differentiation and anti-tumor immunity

L Sun, A Jiao, H Liu, R Ding, N Yuan, B Yang… - … and Targeted Therapy, 2024 - nature.com
CD8+ T cell immune responses are regulated by multi-layer networks, while the post-
translational regulation remains largely unknown. Transmembrane ectodomain shedding is …

Targeted therapy for highly desmoplastic and immunosuppressive tumor microenvironment of pancreatic ductal adenocarcinoma

OT Olaoba, M Yang, TI Adelusi, T Maidens, ET Kimchi… - Cancers, 2024 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is characterized by a highly
desmoplastic and extreme immunosuppressive tumor microenvironment (TME), which …

Sensory nerve release of CGRP increases tumor growth in HNSCC by suppressing TILs

LB Darragh, A Nguyen, TT Pham, S Idlett-Ali, MW Knitz… - Med, 2024 - cell.com
Background Perineural invasion (PNI) and nerve density within the tumor microenvironment
(TME) have long been associated with worse outcomes in head and neck squamous cell …

YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN production

C Wen, L Wang, A Piffkó, D Chen, X Yu… - The Journal of Clinical …, 2024 - jci.org
The RNA N 6-methyladenosine (m6A) reader YTHDF1 is implicated in cancer etiology and
progression. We discovered that radiotherapy (RT) increased YTHDF1 expression in …

Amplifying mRNA vaccines: potential versatile magicians for oncotherapy

C Hu, J Liu, F Cheng, Y Bai, Q Mao, M Xu… - Frontiers in …, 2023 - frontiersin.org
Cancer vaccines drive the activation and proliferation of tumor-reactive immune cells,
thereby eliciting tumor-specific immunity that kills tumor cells. Accordingly, they possess …